These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 16894105)

  • 1. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.
    Boyle PA; Wilson RS; Aggarwal NT; Tang Y; Bennett DA
    Neurology; 2006 Aug; 67(3):441-5. PubMed ID: 16894105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology of older persons without cognitive impairment from two community-based studies.
    Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS
    Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons.
    Wilson RS; Schneider JA; Bienias JL; Evans DA; Bennett DA
    Arch Neurol; 2003 Apr; 60(4):539-44. PubMed ID: 12707067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonian signs in subjects with mild cognitive impairment.
    Boyle PA; Wilson RS; Aggarwal NT; Arvanitakis Z; Kelly J; Bienias JL; Bennett DA
    Neurology; 2005 Dec; 65(12):1901-6. PubMed ID: 16380610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of progression from mild cognitive impairment to Alzheimer disease.
    Palmer K; Berger AK; Monastero R; Winblad B; Bäckman L; Fratiglioni L
    Neurology; 2007 May; 68(19):1596-602. PubMed ID: 17485646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.
    Arvanitakis Z; Wilson RS; Bienias JL; Evans DA; Bennett DA
    Arch Neurol; 2004 May; 61(5):661-6. PubMed ID: 15148141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
    Rozzini L; Chilovi BV; Bertoletti E; Conti M; Del Rio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of cognitive activity to risk of developing Alzheimer disease.
    Wilson RS; Scherr PA; Schneider JA; Tang Y; Bennett DA
    Neurology; 2007 Nov; 69(20):1911-20. PubMed ID: 17596582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly.
    Buchman AS; Boyle PA; Wilson RS; Tang Y; Bennett DA
    Psychosom Med; 2007 Jun; 69(5):483-9. PubMed ID: 17556640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between mild parkinsonian signs and mild cognitive impairment in a community.
    Louis ED; Schupf N; Manly J; Marder K; Tang MX; Mayeux R
    Neurology; 2005 Apr; 64(7):1157-61. PubMed ID: 15824340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
    Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
    Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in body mass index and risk of incident Alzheimer disease.
    Buchman AS; Wilson RS; Bienias JL; Shah RC; Evans DA; Bennett DA
    Neurology; 2005 Sep; 65(6):892-7. PubMed ID: 16186530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community.
    Manly JJ; Bell-McGinty S; Tang MX; Schupf N; Stern Y; Mayeux R
    Arch Neurol; 2005 Nov; 62(11):1739-46. PubMed ID: 16286549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease.
    Palmer K; Bäckman L; Winblad B; Fratiglioni L
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):603-11. PubMed ID: 18591580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semantic inhibition impairment in mild cognitive impairment: a distinctive feature of upcoming cognitive decline?
    Bélanger S; Belleville S
    Neuropsychology; 2009 Sep; 23(5):592-606. PubMed ID: 19702413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.